Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) declared a quarterly dividend on Tuesday, February 11th,Wall Street Journal reports. Stockholders of record on Friday, February 21st will be paid a dividend of 0.47 per share on Monday, March 31st. This represents a $1.88 dividend on an annualized basis and a dividend yield of 13.67%. The ex-dividend date of this dividend is Friday, February 21st.
Abrdn Life Sciences Investors Stock Performance
Shares of HQL traded down $0.02 during mid-day trading on Wednesday, reaching $13.75. 162,026 shares of the company’s stock were exchanged, compared to its average volume of 129,547. The business’s fifty day simple moving average is $13.75 and its 200-day simple moving average is $14.53. Abrdn Life Sciences Investors has a 52-week low of $12.76 and a 52-week high of $15.90.
Insider Buying and Selling
In related news, major shareholder Saba Capital Management, L.P. sold 15,143 shares of the stock in a transaction on Friday, January 31st. The stock was sold at an average price of $14.27, for a total transaction of $216,090.61. Following the completion of the sale, the insider now directly owns 3,381,371 shares of the company’s stock, valued at $48,252,164.17. This trade represents a 0.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold a total of 71,650 shares of company stock valued at $1,006,496 over the last three months. 10.06% of the stock is currently owned by company insiders.
About Abrdn Life Sciences Investors
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.
Featured Stories
- Five stocks we like better than Abrdn Life Sciences Investors
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Most Volatile Stocks, What Investors Need to Know
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Abrdn Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.